» Articles » PMID: 36091122

Active Surveillance of Highly Suspicious Thyroid Nodules Cohort in China Shows a Worse Psychological Status in Younger Patients

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Sep 12
PMID 36091122
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Active surveillance has been considered a safe alternative to surgery for low-risk papillary thyroid microcarcinoma. This study aimed to assess the oncological outcomes and psychological status of active surveillance of highly suspicious thyroid nodules ≤10 mm in China.

Methods: This prospective single-center cohort study enrolled 336 patients with highly suspicious thyroid nodules for active surveillance to assess oncological outcomes and psychological status. The psychological status of patients was assessed by two different questionnaires and compared among different patient groups.

Results: During a median follow-up period of 28.5 months, eight patients underwent delayed surgery for tumor enlargement and one for lymph node metastases. The cumulative incidence of disease progression at 5 and 10 years was 6.0% and 12.8%, respectively. Patients who underwent delayed surgery had no permanent complications, and no patient had distant metastasis or death. Patients ≤30 years old had a higher baseline anxiety score (4.9 vs. 3.8, p=0.024), a higher proportion of baseline anxiety score, i.e., ≥8 points (24.0% vs. 12.6%, p=0.033), and a worse baseline emotional function (62.7 vs. 70.7, p=0.013) than patients >30. During AS, patients ≤30 years of age had higher overall anxiety levels (p=0.005) and a worse overall emotional function (p=0.001).

Conclusions: Active surveillance in Chinese patients with highly suspicious subcentimetre thyroid nodules has good oncological outcomes and can be used as a safe alternative to surgery. Younger patients (≤30) show a worse psychological status; therefore, more attention should be paid to younger patients.

Citing Articles

Differentiated thyroid cancer and adverse pregnancy outcomes: a propensity score-matched retrospective cohort study.

Li X, Mei F, Xiao W, Zhang F, Zhang S, Fu P Front Pediatr. 2024; 12:1377061.

PMID: 39328585 PMC: 11424406. DOI: 10.3389/fped.2024.1377061.


Clinical and molecular features of progressive papillary thyroid microcarcinoma.

Wang Z, Ji X, Zhang H, Sun W Int J Surg. 2024; 110(4):2313-2322.

PMID: 38241301 PMC: 11019976. DOI: 10.1097/JS9.0000000000001117.


The Optimal Age Threshold for Stratifying the Risks of Disease Progression in Patients with Highly Suspicious Sub-centimeter Thyroid Nodules.

Zhuge L, Huang Z, Cai H, Wang S, Niu L, Li Z Ann Surg Oncol. 2023; 30(9):5463-5469.

PMID: 37061650 DOI: 10.1245/s10434-023-13497-1.

References
1.
Hjermstad M, Fayers P, Bjordal K, Kaasa S . Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). J Clin Oncol. 1998; 16(3):1188-96. DOI: 10.1200/JCO.1998.16.3.1188. View

2.
Moon H, Son E, Kim E, Yoon J, Kwak J . The diagnostic values of ultrasound and ultrasound-guided fine needle aspiration in subcentimeter-sized thyroid nodules. Ann Surg Oncol. 2011; 19(1):52-9. DOI: 10.1245/s10434-011-1813-1. View

3.
Du L, Zhao Z, Zheng R, Li H, Zhang S, Li R . Epidemiology of Thyroid Cancer: Incidence and Mortality in China, 2015. Front Oncol. 2020; 10:1702. PMC: 7683719. DOI: 10.3389/fonc.2020.01702. View

4.
Rossi E, Pantanowitz L, Hornick J . A worldwide journey of thyroid cancer incidence centred on tumour histology. Lancet Diabetes Endocrinol. 2021; 9(4):193-194. DOI: 10.1016/S2213-8587(21)00049-8. View

5.
Molinaro E, Campopiano M, Pieruzzi L, Matrone A, Agate L, Bottici V . Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center. J Clin Endocrinol Metab. 2019; 105(3). PMC: 8105780. DOI: 10.1210/clinem/dgz113. View